Registration Brochure - The Liver Meeting 2008 - San Francisco - Oct 31-Nov 4, 2008 - (Page 15)

pOsTgraduaTe cOurse MeeT-The-prOfessOr LuncheOns SAtURdAy, NOveMbeR 1 • NOON – 1:30 pM 1.5 CME Credits Goals and Objectives: The goal of the Meet-the-Professor Luncheons is to provide the attendee with an opportunity to explore in more detail a wide variety of topics in hepatology in a small group setting. Topic moderators are experts in their particular specialty area for a given session. PG-1. HFE and Beyond: New Mutations and Phenotypic Expression in Genetic Hemochromatosis Pierre Brissot, MD and Bruce R . Bacon, MD Nutrition in Chronic Liver Disease in Children Ross W . Shepherd, MD and TBA Hepatitis C – Optimizing Current Therapies Using Viral kinetics Jean-Michel Pawlotsky, MD, PhD and David R . Nelson, MD Maintenance Therapy in HCV Non-responders: Does It Make Sense and Where Is the Data? (A Critical Re-assessment) Thierry Poynard, MD, PhD and Mitchell L . Shiffman, MD Emerging Therapies for HCV and the Role of Interferon Yves Benhamou, MD and John G . McHutchison, MD HIV Co-infection with HBV and HCV: Changing Paradigms in Natural History and Treatment Mauricio Bonacini, MD and Margaret C . Shuhart, MD HBV: Can We Resist Resistance and Is It All About Viral Load? Anna S . F . Lok, MD and Marc Ghany, MD PG-8. Non-invasive Markers of Liver Fibrosis: Fibroscan, Serum Markers, and Other Technologies; Is Biopsy Obsolete? Nezam H . Afdhal, MD and K . Rajender Reddy, MD Prognosis and Treatment of NASH in the Liver and Beyond: Lifestyle or Pharmacology? Zobair M . Younossi, MD, MPH and Giulio Marchesini, MD Steatosis as a Co-factor in Chronic Liver Diseases: Where Is the Evidence? Elizabeth E . Powell, MD and Arun Sanyal, MD Cholangiocarcinoma: How to Diagnose and When to Transplant Gregory J . Gores, MD and Julie Heimbach, MD HCC: Diagnostic Serum Markers and Imaging Jorge A . Marrero, MD and Ricardo Lencioni, MD HCC: Small Molecules and Other Emerging Treatments Jordi Bruix, MD and Adrian M . Di Bisceglie, MD Management of Acute Liver Failure: Current and Future Prospects, and the Role of Liver Assist Devices Julia Wendon, MbChB, FRCP and Didier Samuel, MD Assessing Surgical Risk in Patients with Liver Disease Jacques Belghiti, MD and Patrick S . Kamath, MD Autoimmune Hepatitis and Overlap Syndromes: Does the Diagnosis Matter? E . Jenny Heathcote, MD and Olivier Chazouilleres, MD PG-9. PG-10. PG-2. PG-11. PG-3. PG-12. PG-4. PG-13. PG-5. PG-14. PG-6. PG-15. PG-7. PG-16. Register Today! Go to www.aasld.org and select the liver Meeting® 2008. | 15 | http://www.aasld.org/thelivermeeting/Pages/default.aspx

Table of Contents Feed for the Digital Edition of Registration Brochure - The Liver Meeting 2008 - San Francisco - Oct 31-Nov 4, 2008

Registration Brochure - The Liver Meeting 2008 - San Francisco - Oct 31-Nov 4, 2008

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.